Market Overview

Morning Market Movers

Share:

Chembio Diagnostics (NASDAQ: CEMI) gained 21.56% to $4.85 after the company reported that it has partnered with Integrated BioTherapeutics to develop point-of-care diagnostic tests for Ebola and Febrile Illness.

Alexza Pharmaceuticals (NASDAQ: ALXA) shares surged 16.70% to $2.65. Ferrer purchased $8 million of Alexza common stock through new investment and elimination of potential milestone payments.

NQ Mobile (NYSE: NQ) shares jumped 14.21% to $10.21 after the company filed its SEC Form 20-F,l which showed full compliance and no attempts to delete documents.

Digital Power (NYSE: DPW) shares gained 11.89% to $2.07 after the company reported that it has been awarded an additional $1.6 million defense export order.

Prosensa Holding N.V. (NASDAQ: RNA) shares climbed 11.66% to $13.41 on the FDA requirement of additional data from Sarepta on Eteplirsen.

Vanda Pharmaceuticals (NASDAQ: VNDA) shares surged 9.27% to $12.14 on Q3 results. Vanda Pharma posted a quarterly loss of $0.64 per share on revenue of $10.90 million.

Novavax (NASDAQ: NVAX) shares surged 6.35% to $5.46 after the company announced Ebola vaccine development program at the 8th Vaccine And ISV Conference in Philadelphia.

CorMedix (NYSE: CRMD) shares gained 4.25% to $1.89 after the company received an approval from the FDA to initiate a clinical trial for Neutrolin in the US.

Micron Technology (NASDAQ: MU) rose 3.04% to $32.01 after the company announced a new $1 billion stock repurchase authorization.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (ALXA + CEMI)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

New Mobile Payment Start-Up Takes On Coin And Plastic -- But Not Apple Pay

Morgan Stanley Sees CenturyLink Inching Towards Revenue Stability